Journal of Child Neurology · 1992 · 13 citations · 24 references
MedicineNeurosciencePharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyChild PsychopharmacologyDrug DependenceStimulant PharmacologyStimulant PharmacotherapyCocaine ToxicityDevelopmental Seizure PharmacologyMetabolite-metabolite InteractionsPhenobarbital TherapyStereotyped Behaviors
A major metabolite of cocaine, benzoylecgonine, causes behavioral activation that progresses to seizures when given intraventricularly to 2-week-old rats. The seizures are characterized by running, hopping, and vocalizing and are mixed with shorter-duration tonic episodes. Pretreatment with haloperidol, at a dose aimed at blocking stereotyped behavior, did not suppress these behaviors. In contrast, seizures were prevented by antiepileptic drugs, with the order of potency being diazepam greater than phenobarbital greater than phenytoin. We hypothesize that the long-lasting cocaine metabolite, benzoylecgonine, contributes to the infant cocaine intoxication syndrome.
24
Ira J. Chasnoff, William J. Burns, Sidney H. Schnoll et al. · New England Journal of Medicine · 1985 · 797 citations
Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801
Ralph Karler, L.I. Calder, Imtiaz A. Chaudhry et al. · Life Sciences · 1989 · 488 citations
Medicine, Pharmacology, Psychiatry +12
Teratogenicity of cocaine in humans
Nesrin Bingol, Magdalena Fuchs, Vivien Diaz et al. · The Journal of Pediatrics · 1987 · 443 citations
Medicine, Pharmacology, Toxicology +10
Perinatal cerebral infarction and maternal cocaine use
Ira J. Chasnoff, Mary E. Bussey, Renate Savich et al. · The Journal of Pediatrics · 1986 · 375 citations
Medicine, Neuroscience, Obstetrics +14
Hydrolysis of cocaine in human plasma by cholinesterase
David J. Stewart, T. Inaba, Bing Tang et al. · Life Sciences · 1977 · 226 citations